Association of HLA-DR, DQ genotype with different β-cell functions at IDDM diagnosis in Japanese children

Diabetes

Volumn 46, Issue 11, 1997, Pages 1893-1897

  Sugihara, Shigetaka ^a   Sakamaki, Tateo ^b   Konda, Susumu ^a   Murata, Atsushi ^a   Wataki, Kunio ^a   Kobayashi, Yasuyuki ^a   Minamitani, Kanshi ^a   Miyamoto, Shigeki ^c   Sasaki, Nozomu ^d   Niimi, Hiroo ^a  

^a CHIBA UNIVERSITY   (Japan)

^b SAKURA NATIONAL HOSPITAL   (Japan)

^c CHIBA CHILDREN'S HOSPITAL   (Japan)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C PEPTIDE; GLUTAMATE DECARBOXYLASE; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; DIABETOGENESIS; FEMALE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENOTYPE; HELPER CELL; HLA SYSTEM; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; JAPAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 15144344271     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.11.1893     Document Type: Article

References (40)

1. Aparicio JMR, Wakisaka A, Takada A Matsuura N, Aizawa M: HLA-DQ system and insulin-dependent diabetes mellitus in Japanese: does it contribute to the development of IDDM as it does in Caucasians? Immunogenetics 28:240-246, 1988
2. Yamagata K, Nakajima H, Hanafusa T, Noguchi T, Miyazaki A, Miyagawa J, Sada M, Amemiya H, Tanaka T, Kono N, Tarui S: Aspartic acid at position 57 of DQ β chain does not protect against type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 32:762-764, 1989
3. Awata T. Kuzuya T, Matsuda A, Iwamoto Y, Kanazawa Y: Genetic analysis of HLA class II alleles and susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 35:419-424, 1992
4. Ikegami H, Kawaguchi Y, Yamato E, Kuwata S, Tokunaga K, Noma Y, Shima K, Ogihara T: Analysis by polymerase chain reaction of histocompatibility leukocyte antigen-DR9-Iinked susceptibility to insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 75:1381-1385, 1992
5. Thorsby E, Ronningen KS: Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36:371-377, 1993
6. Todd JA, Bell JI, McDevitt HO: HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599-604, 1979
7. Morel PA, Dorman JS, Todd JA, McDevitt HO, Trucco M: Aspartic acid at position 57 of the HLA-DQβ chain protects against type 1 diabetes: a family study. Proc Natl Acad Sci USA 85:8111-8115, 1988
8. Horn GT, Bugawan TL, Long CM, Erlich HA Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility. Proc Natl Acad Sci USA 85:6012-6016, 1988
9. Karjalainen J, Salmela P, IIonen J, Surcel H-M, Knip M: A comparison of childhood and adult type 1 diabetes mellitus. N Engl J Med 320:881-886, 1989
10. Caillat-Zucman S, Garchon H-J, Timsit J, Assan R, Boitard C, Djilali-Saiah I, Bougneres P, Bach J-F: Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest 90:2242-2250, 1992
11. Ludvigsson J, Lindblom B: Human lymphocyte antigen DR types in relation to early clinical manifestations in diabetic children. Pediatr Res 18:1239-1241, 1984
12. Eberhardt MS, Wagener DK, Orchard TJ, LaPorte RE, Cavender DE, Rabin BS, Atchelson RW, Kuller LH, Drash AL, Becker DJ: HLA heterogeneity of insulin-dependent diabetes mellitus at diagnosis: the Pittsburgh IDDM study. Diabetes 34:1247-1252, 1985
13. Ludvigsson J, Samuelsson U, Beauforts C, Deschamps I, Dorchy H, Drash A Francois R, Herz G, New M, Schober E: HLA-DR3 is associated with a more slowly progressive form of type 1 (insulin-dependent) diabetes. Diabetologia 29:207-210, 1986
14. Mustonen A Ilonen J, Tiilikainen A Kataja M, Akerblom HK: An analysis of epidemiological data in HLA-typed diabetic children. Diabetologia 28:397-400, 1985
15. Knip M, Ilonen J, Mustonen A Akerblom HK: Evidence of an accelerated β-cell destruction in HLA-Dw3/Dw4 heterozygous children with type 1 (insulin-dependent) diabetes. Diabetologia 29:347-351, 1986
16. Veijola R, Knip M, Reijonen H, Vahasalo P, Puukka R, Ilonen J: Effect of genetic risk load defined by HLA-DQB1 polymorphism on clinical characteristics of IDDM in children. Euro J Clin Invest 25:106-112, 1995
17. Serjeantson SW, Kohonen-Corish MRJ, Rowley MJ, Mackay IR, Knowles W, Zimmet P: Antibodies to glutamic acid decarboxylase are associated with HLA-DR genotypes in both Australians and Asians with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:996-1001, 1992
18. Awata T, Hagura R, Urakami T, Kanazawa Y: Age-dependent HLA genetic heterogeneity of IDDM in Japanese patients. Diabetologia 38:748-749, 1995
19. Kida K, Mimura G, Kobayashi T, Nakamura K, Sonoda S, Inouye H, Tsuji K: Immunogenetic heterogeneity in type 1 (insulin-dependent) diabetes among Japanese: HLA antigens and organ-specific autoantibodies. Diabetologia 32:34-39, 1989
20. Kobayashi T, Tamemoto K, Nakanishi K, Kato N, Okubo M, Kajio H, Sugimoto T, Murase T, Kosaka K: Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 16:780-788, 1993
21. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. In: Definition, diagnosis, and classification. Geneva, World Health Org., 1985, p. 9-20 (Tech. Rep. Ser., no. 727
22. Yamaguchi A Ogata K, Kubo H, Ohta K, Mizushima Y, Ishige H, Yamane R, Kawasaki E, Nagataki S, Tsuruoka A, Matsuba I, Ikeda Y, Watanabe H: Performance and characteristic study of 'RIP Anti-GAD Hoechst' RIA kit in detection of anti-GAD antibodies. Med Pharm, 31:419-431, 1994 (in Japanese)
23. Kawasaki E, Takino H, Yano M, Uotani S, Matsumoto K, Takao Y, Yamaguchi Y, Akazawa S, Nagataki S; Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 43:80-86, 1994
24. Tsuruoka A, Matsuba I, Toyota T, Isshiki G, Nagataki S, Ikeda Y: Antibodies to GAD in Japanese diabetic patients: a multicenter study. Diabetes Res Clin Practice 28:191-199, 1995
25. Sugihara S, Konda S, Wataki K, Kobayashi Y, Murata A, Miyamoto S, Kubo H, Yamaguchi A, Sasaki N, Niimi H: Clinical significance and time course of antibodies to glutamic acid decarboxylase in Japanese children with type 1 (insulin-dependent) diabetes mellitus. Acta Paediatr 85:558-563, 1996
26. Schmidli RS, Colman PG, Bonifacio E, Bottazzo GF; Harrison LC, participating laboratories: High level of concordance between assays for glutamic acid decarboxylase antibodies: the first international glutamic acid decarboxylase antibody workshop. Diabetes 43: 1005-1009, 1994
27. Schmidli RS, Colman PG, Bonifacio E, participating laboratories: Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies: the second international GADAb workshop. Diabetes 44:636-640, 1995
28. Kimura A, Sasazuki T: Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: HLA 1991, Eds. Tsuji K, Oxford Press, Oxford, vol.1, 1992, p.397-419
29. Sakamaki T, Omori K, Kashiwabara H, Yokoyama T, Mimura N: DNA typing of HLA-D/DR antigens using digoxigenin-labelled sequence specific oligonucleotide (DIG-SSO) probes, combined with polymerase chain reaction (PCR). IRYO 45:644-650, 1991 (in Japanese)
30. Sakamaki T: PCR-sequence-speciflc primers assay. Transplantation Now Suppl 7:78-81, 1994 (in Japanese)
31. Sakamaki T, Kashiwabara H: Two-step procedure for "high resolution" DRB typing in Japanese using polymerase chain reaction with sequence-specific primers (PCR-SSP). MHC& IRS Suppl 1:153-155, 1994
32. Akaza T, Imanishi T, Fujiwara K, Tokunaga K, Juji T, Yashiki S, Sonoda S: HLA allele and haplotype frequencies in Japanese. Transplantation Now Suppl 7:87-101, 1994 (in Japanese)
33. Rammensee H-G, Friede T, Stevanovic S: MHC ligands and peptide motife: first listing. Immunogenetics 41:178-228, 1995
34. Yasunaga S, Kimura A, Hamaguchi K, Ronningen KS, Sasazuki T. Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM). Tissue Antigens 47:37-48, 1996
35. Harrison LC, Honeyman MC, DeAizpurua HJ, Schmidli RS, Colman PG, Tait BD, Cram DS: Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341:1365-1369, 1993
36. Katz JD, Benoist C, Mathis D: T helper cell subset in insulin-dependent diabetes. Science 268:1185-1188, 1995
37. Liblau RS, Singer SM, McDevitt HO: Th1 and Th2 CD4 T cells in the pathogenesis of organ-specific autoimmune diseases. Immunology Today 16:34-38, 1995
38. Mosman TR, Coffman RL: Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173, 1989
39. + T cells. Annu Rev Immunol 12:635-673, 1994
40. Murray JS, Madri J, Pasqualini T, Bottomly K; Functional C D4 T cell subset interplay in an intact immune system. J Immunol 150: 4270-4276, 1993